BRAF Mutation Diversity and Impact on Clinical Outcomes in Non-Small Cell Lung Cancer

被引：0
作者：
Lu, K. [1 ]
Shen, J. P. [2 ]
Lopez-Diaz, F. J. [3 ]
Leal, A. [4 ]
Woodward, B. D. [1 ]
Velcheti, V. [4 ]
Riess, J. W. [5 ]
Mansfield, A. S. [6 ]
Salgia, R. [7 ]
Husain, H. [1 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] CEPIMP Genom, Cordoba, Argentina
[4] NYU Langone, New York, NY USA
[5] Univ Calif Davis, Sacramento, CA USA
[6] Mayo Clin, Rochester, MN USA
[7] City Hope Natl Med Ctr, Duarte, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
BRAF; NSCLC; Targeted Therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.12C.01
引用
收藏
页码：S341 / S341
页数：1
相关论文
共 50 条
  • [21] Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer
    Nicos, Marcin
    Krawczyk, Pawel
    Jarosz, Bozena
    Sawicki, Marek
    Szumillo, Justyna
    Trojanowski, Tomasz
    Milanowski, Janusz
    CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 16 (02) : 169 - 176
  • [22] Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer
    Marcin Nicoś
    Paweł Krawczyk
    Bożena Jarosz
    Marek Sawicki
    Justyna Szumiłło
    Tomasz Trojanowski
    Janusz Milanowski
    Clinical and Experimental Medicine, 2016, 16 : 169 - 176
  • [23] The incidence and clinical impact of bone metastases in non-small cell lung cancer
    Kuchuk, Michael
    Kuchuk, Iryna
    Sabri, Elham
    Hutton, Brian
    Clemons, Mark
    Wheatley-Price, Paul
    LUNG CANCER, 2015, 89 (02) : 197 - 202
  • [24] Ongoing Progress in BRAF-Mutated Non-Small Cell Lung Cancer
    Abdayem, Pamela
    Planchard, David
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (11) : 662 - +
  • [25] BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?
    Caparica, Rafael
    de Castro, Gilberto, Jr.
    Gil-Bazo, Ignacio
    Caglevic, Christian
    Calogero, Raffaele
    Giallombardo, Marco
    Santos, Edgardo S.
    Raez, Luis E.
    Rolfo, Christian
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 101 : 32 - 39
  • [26] BRAF MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER: A POOLED ANALYSIS
    Huang, Zhi-min
    An, She J.
    Wu, Yi-long
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S458 - S458
  • [27] Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes
    Di Federico, Alessandro
    De Giglio, Andrea
    Gelsomino, Francesco
    De Biase, Dario
    Giunchi, Francesca
    Palladini, Arianna
    Sperandi, Francesca
    Melotti, Barbara
    Ardizzoni, Andrea
    CANCERS, 2022, 14 (14)
  • [28] Clinical and Imaging Features of Non-Small Cell Lung Cancer with G12C KRAS Mutation
    Wu, Markus Y.
    Zhang, Eric W.
    Strickland, Matthew R.
    Mendoza, Dexter P.
    Lipkin, Lev
    Lennerz, Jochen K.
    Gainor, Justin F.
    Heist, Rebecca S.
    Digumarthy, Subba R.
    CANCERS, 2021, 13 (14)
  • [29] The Clinical Implication of Frameshift Indel Mutation Burden in Non-Small Cell Lung Cancer (NSCLC)
    Chae, Y. K.
    Park, W.
    Saravia, D.
    Florou, V.
    Chang, S.
    Wang, S.
    Cliec, L.
    Rahbari, A.
    Mohindra, N.
    Villaflor, V.
    Park, L. C.
    Lopes, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S423 - S423
  • [30] CLINICAL EXPERIENCE USE GEFITINIB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WITH A MUTATION EGFR
    Vozniy, Eduard
    Popov, Anatoly
    Galkin, Michail
    Astrakhankina, Tamara
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1214 - S1214
12345